Biotech Co.* | Agbiotech | Type/Product | Disclosed | Terms/Details |
AviGenics | Demegen | Expanded research and development collaboration to develop disease-resistant poultry | ND | Demegen granted AviGenics an exclusive worldwide license for the antimicrobial peptide library and an additional license for Demegen's technologies for transgenic poultry creation; the collaboration will expand the incorporation of Demegen peptides into the poultry genome to impart resistance to Salmonella and Marek's disease, as well as to coccidiosis (1/26) |
ComGenex (Hungary)* | Aventis Crop- | Extended 1998 agreement to continue to provide access to in-house design and synthesis technologies and product management capabilities to Aventis | ND | Financial details not available (1/12) |
CytRx Corp. (CYTR) | Ivy Animal | Licensing agreement providing Ivy with an exclusive worldwide license to CRL-876 | ND | The nonantibiotic feed additive is designed to enhance growth performance in monogastric food animals, including poultry and swine (2/20) |
Genencor | Cargill Inc.* | Agreement to supply biocatalysts for Cargill's wet corn-milling facilities | $70 | Five-year exclusive supply agreement is valued at $70M (1/18) |
GeneScan | Clinical Micro Sensors (unit of Motorola Inc.; NYSE:MOT) | Technical collaboration to develop and deliver new DNA detection tools for genetically modified crops using Motorola's DNA detection system | ND | No further details were disclosed (1/30) |
Genetic Technologies Ltd. (OTC | University of Melbourne (Australia) | Collaboration studying infectious diseases in livestock | ND | Collaboration will pursue a genomics approach to the diagnosis and treatment of infectious diseases in agricultural animals and common worms in domestic animals (1/5) |
Genometrix | AniGenics | Agreement to genotype cattle for single nucleotide poly- morphisms associated with parentage confirmation, improved productivity and meat quality | ND | Financial terms were not disclosed (3/14) |
GenomicFX | Incyte | Partnership calling for GenomicFX to use Incyte's gene databases and custom genomics services to develop advanced genetic information tools for use in improving meat quality, food safety and livestock production efficiency | ND | GenomicFX gains access to Incyte's LifeSeq Gold and Zooseq databases in addition to custom services from Incyte enabling the company to create database resources for cattle and swine (2/14) |
Geron | Clone Australia | Licensing agreement for access to Geron's nuclear transfer technology to produce superior cattle and sheep for agricultural applications in Australia, New Zealand and China | ND | Geron will receive equity in Clone Australia, in addition to a share of revenues (1/10) |
Geron | Viragen Inc. | Option agreement to license nuclear transfer technology | ND | Viragen has the option to license, on a nonexclusive worldwide basis, Geron's nuclear transfer patent portfolio for the field of avian nuclear transfer; Geron will receive cash and Viragen stock (6/7) |
Geron | ProLinia | Nonexclusive licensing agreement for nuclear transfer technology for agricultural applications | ND | ProLinia gains access to Geron's patents for use in swine worldwide and bovine everywhere except Australia and New Zealand (6/6) |
Infigen | Immerge BioTherapeutics | Partnership to use nuclear transfer technology to develop swine with more human organs | ND | Infigen will provide Immerge with exclusive access to its porcine NT technology; Immerge will provide the vectors for specific genes and cells from miniature swine (5/8) |
Lynx Therapeutics | AniGenics | Agreement to use Lynx's Megasort and Megatype technologies to identify genes associated with commercially valuable traits in certain food animal species | ND | Lynx will receive payments for performing services, as well as royalties on sales of products and services from AniGenics; Lynx also retains rights to human health care applications of any discoveries and will pay royalties to AniGenics on any related products or services (5/8) |
Meristem | Goodwin | Partnership agreement to expand the use of corn- and tobacco-based plant cultivation systems in North America | ND | The companies will set up a pilot manufacturing facility to cultivate genetically modified plants and the extraction and purification of recombinant proteins (4/4**) |
Microscience Ltd. (UK)* | Merial (joint | Collaboration to use functional genomics to develop two avian vaccines | ND | Deal includes up-front fees and milestone and royalty payments (6/5) |
Myriad Genetics | Torrey Mesa | Expanded agreement to include the use of Myriad's ProNet technology to elucidate the rice proteome | ND | Expanded agreement follows the collaboration's accomplishment of sequencing the entire rice genome (1/26) |
Neogen | Monsanto Co. (NYSE:MON) | Nonexclusive agreement for access to Monsanto technology | ND | Neogen will develop tests for rapid detection of genetically enhanced grains; it also will market the tests (4/12) |
Phytomedics | Vilmorin Clause | Strategic collaboration combining Vilmorin's germplasm collections and Phytomedics' discovery and manufacturing platforms | ND | Companies will focus on developing and commercializing health-promoting crops and plant-derived therapeutic agents (6/14) |
Sangamo | Renessen | Agreement to apply Sangamo's gene regulation technology to enhance the value of certain crops for the animal feed and processing industries | ND | Sangamo will receive certain payments, research funding and royalties; Renessen gets a worldwide exclusive license (1/9) |
Targeted | CropDesign | Research collaboration | ND | TGI will give CropDesign several of its yield-enhancing genes for use in CropDesign's high-throughput Trait-Mill system and for use in commercial development in cereal crops (5/9) |
Third Wave | ValiGen NV* | Agreement in which Third Wave will develop and supply custom-designed Invader assays to ValiGen | ND | ValiGen will use the platform to analyze genetic variations in several plant species (7/18) |
ValiGen | Agricore (farmer-owned cooperative) | Agreement to develop and market specialty canola products | ND | ValiGen and Agricore will develop the products using ValiGen's Genoplasty system to change specific DNA sequences (5/17) |
ViaLactia Biosciences Ltd. (New Zealand)* | Orion | Genomics alliance to develop improved varieties of forage plant species and hardier, higher-yielding crops | ND | Orion will use its GeneThresher technology to sequence and identify the complete gene set of a key forage grass species (6/1) |
Vical Inc. | Merial (joint | Agreement to extend options under a 1995 deal for developing and commercializing vaccines for animal health applications using Vical's naked DNA technology | $1 | Vical will receive $1M and Merial will receive a renewable one-year extension of its options against additional infectious disease targets in domesticated animals; Vical also will receive royalties on any vaccines sold (7/23) |
Notes: |
||||
This chart contains information on new corporate agreements in agricultural biotechnology covering the time between 12/21/00 and 7/25/01. |
||||
Unless otherwise indicated, shares are traded on the Nasdaq exchange. |
||||
AMEX = American Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over the Counter Bulletin Board |
||||
ND = Not disclosed, reported and/or available |
||||
* Private companies are indicated with an asterisk. |
||||
** Denotes the date the item ran in BioWorld International. |
||||
To read more on related topics, click on one of the words below.